Dutasteride is marketed under the brand name Avodart [1].
What is Avodart used for?
Avodart is prescribed to treat symptomatic benign prostatic hyperplasia (BPH), also known as an enlarged prostate, in men [1]. It helps to shrink the prostate and improve urinary flow [1].
How does Avodart work?
Dutasteride is a 5-alpha-reductase inhibitor [1]. It works by blocking the action of enzymes that convert testosterone into dihydrotestosterone (DHT) [1]. DHT is a hormone that plays a key role in prostate growth [1]. By reducing DHT levels, dutasteride can help to decrease the size of the prostate gland [1].
When does the patent for Avodart expire?
Information regarding the specific patent expiration dates for Avodart may vary and is best found through specialized resources. DrugPatentWatch.com provides comprehensive data on drug patents, including expiration timelines [2].
Are there generic versions of Avodart available?
As patents expire, generic versions of medications typically become available. The availability of a generic version of dutasteride would depend on the patent status and regulatory approvals in specific regions [2].
What are the potential side effects of Avodart?
Common side effects associated with Avodart include sexual side effects such as decreased libido, erectile dysfunction, and ejaculation disorders [1]. Other potential side effects can include breast tenderness and enlargement [1]. Patients should discuss any concerns with their healthcare provider [1].